✦ LIBER ✦

Clinicopathological Significance of Plasminogen Activator Inhibitor-1 Promoter 4G/5G Polymorphism in Breast Cancer: A Meta-analysis

✍ Scribed by Lee, Ju-Han; Kim, Younghye; Choi, Jung-Woo; Kim, Young-Sik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO-32 Plasminogen activator inhibitor-1

✍ R. Palmirotta; P. Ferroni; A. Savonarola; F. Martini; F. Ciatti; A. Laudisi; E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Plasminogen Activator Inhibitor-1 -675 4

✍ Liu, Ying; Sun, Mei-Guo; Jiang, Rong; Ding, Rui; Che, Zhen; Chen, Yan-Yan; Yao, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 294 KB

Plasminogen activator inhibitor-1 4G/5G

✍ Tengyue Zhang, Chong Pang, Ningdong Li, Elaine Zhou, Kanxing Zhao 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 436 KB

4G/5G promoter polymorphism in the plasm

✍ Peter WM Hermans; Martin L Hibberd; Robert Booy; Olufunmilayo Daramola; Jan A Ha 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 57 KB

4G/5G promoter polymorphism of plasminog

✍ Chih-Hung Chen; Hock-Liew Eng; Chih-Jen Chang; Tzu-Tung Tsai; Ming-Liang Lai; Hs 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Plasminogen-activator-inhibitor-1 4G/5G

✍ Thilo Menges; Peter WM Hermans; Simon G Little; Tanja Langefeld; Olav Böning; Jö 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 76 KB